speb/financial-data huggingface dataset:
Financial ratios for PGNY — quarterly report dated 2025-12-31
Total revenue: 318403000
Gross profit: 76881000
Operating income: 15222000
Net income: 12485000
Capital expenditures: 5614000
Operating cash flow: 54203000
Depreciation & amortization: 1367000
Net tangible assets: 489850000
Owner earnings: 8238000
Return on net tangible assets (%): 1.6817393079514138
Capex to operating income (%): 36.8808303770858
Buffett classification: The Good
Stock price: 25.68
P/E ratio: 34.374150061517426
Shares outstanding: 78332370
Book value: 516044000
P/B ratio: 3.8980692762632647
Market cap (USD): 2011575261.6
Debt to equity: 0.05372797668415871
Current ratio: 2.726282295161346
Quick ratio: 2.726282295161346
Effective tax rate (%): 30.07169261790075
COGS to revenue (%): 75.85418479097244
SG&A to revenue (%): 19.365081359158047
Free cash flow (dilution-adjusted): 13790000
Buyback yield (%): 4.059355946495898
Retained earnings: 202827000
Receivables turnover: 1.4454007726284348
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.8186592203598226
FCF margin (%): 4.3309893436933695
Revenue growth (%): 1.6138709286220343
Rule of 40 score: 5.944860272315404
Financial ratios for PGNY — annual report dated 2025-12-31
Total revenue: 1288661000
Gross profit: 304484000
Operating income: 85277000
Net income: 58520000
Capital expenditures: 18410000
Operating cash flow: 210192000
Depreciation & amortization: 4948000
Net tangible assets: 489850000
Owner earnings: 45058000
Return on net tangible assets (%): 9.198326018168828
Capex to operating income (%): 21.588470513737583
Buffett classification: The Great
Stock price: 25.68
P/E ratio: 34.374150061517426
Shares outstanding: 78332370
Book value: 516044000
P/B ratio: 3.8980692762632647
Market cap (USD): 2011575261.6
Debt to equity: 0.05372797668415871
Current ratio: 2.726282295161346
Quick ratio: 2.726282295161346
Effective tax rate (%): 38.67884986168162
COGS to revenue (%): 76.37206371574837
SG&A to revenue (%): 17.010447278221346
Free cash flow (dilution-adjusted): 59915000
Buyback yield (%): 4.059355946495898
Retained earnings: 202827000
Receivables turnover: 5.849918515391285
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.790750383302102
FCF margin (%): 4.649399648161929
Revenue growth (%): 10.404199376125
Rule of 40 score: 15.053599024286928
Financial ratios for PRNR3.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1649122807017542
Shares outstanding: 56987156
Market cap (USD): 66385037.86666666
Buyback yield (%): 1.7797806809535226
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRNR3.SA — annual report dated 2022-12-31
Total revenue: 154070833.3333333
Gross profit: 37610227.27272727
Operating income: 19983712.12121212
Net income: 12298106.06060606
Capital expenditures: 13652840.909090908
Operating cash flow: 17671212.12121212
Depreciation & amortization: 4980681.818181818
Net tangible assets: 34848295.45454545
Owner earnings: 3625946.9696969707
Return on net tangible assets (%): 10.404947852977466
Capex to operating income (%): 68.31984381219553
Buffett classification: The Good
Stock price: 1.2599620493358634
P/E ratio: 5.83843182891237
Shares outstanding: 56987156
Book value: 42000378.78787878
P/B ratio: 1.709547769133557
Market cap (USD): 71801653.85958254
Debt to equity: 0.7089266871691273
Current ratio: 1.3657196224172399
Quick ratio: 1.3450305261614222
Effective tax rate (%): 22.862912805892137
Interest coverage ratio: 7.594759951054487
COGS to revenue (%): 75.58900250032576
SG&A to revenue (%): 3.1445837338689655
Free cash flow (dilution-adjusted): 4018371.212121212
Buyback yield (%): 1.4235871125030848
Inventory turnover: 114.70098862152584
Receivables turnover: 3.96298587734383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 29.243078901493003
FCF margin (%): 2.608132327958166
Rule of 40 score: 2.608132327958166
Financial ratios for PRNR3.SA — annual report dated 2023-12-31
Total revenue: 215754845.36082476
Gross profit: 44447628.86597939
Operating income: 18168247.422680415
Net income: 5171134.020618557
Capital expenditures: 18771134.020618558
Operating cash flow: 4462268.041237114
Depreciation & amortization: 8053814.432989691
Net tangible assets: 33976288.65979382
Owner earnings: -5546185.56701031
Return on net tangible assets (%): -16.323694511029522
Capex to operating income (%): 103.31835308003086
Buffett classification: The Gruesome
Stock price: 2.401656314699793
P/E ratio: 26.46683735491561
Shares outstanding: 56987156
Book value: 49217319.58762887
P/B ratio: 2.780800828060207
Market cap (USD): 136863563.0641822
Debt to equity: 1.5666641530933707
Current ratio: 1.6069000115493446
Quick ratio: 1.5902653461916036
Effective tax rate (%): 40.86439838721086
Interest coverage ratio: 2.3938060309698455
COGS to revenue (%): 79.39901243392892
SG&A to revenue (%): 3.7079120919027035
Free cash flow (dilution-adjusted): -14733608.247422682
Buyback yield (%): 0
Inventory turnover: 180.26469950097635
Receivables turnover: 3.781370154086323
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.736910910610574
FCF margin (%): -6.8288655222469945
Revenue growth (%): 40.03613837411891
Rule of 40 score: 33.20727285187192
Financial ratios for PRNR3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.2449355432780846
Shares outstanding: 56987156
Market cap (USD): 127932492.01473296
Buyback yield (%): 0
Retained earnings: -235911.60220994477
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRNR3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 905825.2427184467
Buffett classification: The Gruesome
Stock price: 2.1599353796445877
Shares outstanding: 56987156
Market cap (USD): 123088574.42972535
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PRNR3.SA — annual report dated 2024-12-31
Total revenue: 178087864.07766992
Gross profit: 39886569.57928803
Operating income: 13787055.01618123
Net income: 4501132.686084143
Capital expenditures: 10569902.91262136
Operating cash flow: 17443042.071197413
Depreciation & amortization: 7886084.142394822
Net tangible assets: 17761974.110032365
Owner earnings: 1817313.9158576056
Return on net tangible assets (%): 10.231486120853795
Capex to operating income (%): 76.66541476925967
Buffett classification: The Gruesome
Stock price: 2.1599353796445877
P/E ratio: 27.346133298907237
Shares outstanding: 56987156
Book value: 57386731.39158577
P/B ratio: 2.1448960664759693
Market cap (USD): 123088574.42972535
Debt to equity: 1.3774369096292118
Current ratio: 1.1151377270915097
Quick ratio: 1.1045709081465824
Effective tax rate (%): 26.561592481123608
Interest coverage ratio: 1.681049620203216
COGS to revenue (%): 77.60287047864631
SG&A to revenue (%): 3.738654876551791
Free cash flow (dilution-adjusted): 6080582.524271845
Buyback yield (%): 0
Inventory turnover: 147.81654551748008
Receivables turnover: 3.6877123499728595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.48673712841977
FCF margin (%): 3.4143722009153334
Revenue growth (%): -17.45823192066033
Rule of 40 score: -14.043859719744997
Financial ratios for PRNR3.SA — quarterly report dated 2025-03-31
Total revenue: 64035590.27777778
Gross profit: 12819444.444444444
Operating income: 3607118.0555555555
Net income: 697395.8333333334
Capital expenditures: 6423.611111111111
Operating cash flow: -6688888.888888889
Depreciation & amortization: 3205555.5555555555
Net tangible assets: 20512673.611111112
Owner earnings: 3896527.777777778
Return on net tangible assets (%): 18.99570895364485
Capex to operating income (%): 0.17808153246378208
Buffett classification: The Great
Stock price: 2.901041666666667
P/E ratio: 59.26408867064974
Shares outstanding: 56987156
Book value: 62517534.72222224
P/B ratio: 2.644411919878034
Market cap (USD): 165322114.02083334
Debt to equity: 1.8665568826523664
Current ratio: 1.957756638453547
Quick ratio: 1.9410626449430568
Effective tax rate (%): 31.298101590559263
Interest coverage ratio: 1.2644230769230769
COGS to revenue (%): 79.98075072184793
SG&A to revenue (%): 14.150930607707842
Free cash flow (dilution-adjusted): -7247743.055555556
Buyback yield (%): 0
Retained earnings: 313020.8333333334
Inventory turnover: 43.50464533254682
Receivables turnover: 0.9820520466684062
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.062878219989376
FCF margin (%): -11.318304436823055
Rule of 40 score: -11.318304436823055
Financial ratios for PRNR3.SA — quarterly report dated 2025-06-30
Total revenue: 66039051.094890505
Gross profit: 13102737.226277372
Operating income: 5788686.131386861
Net income: 92700.7299270073
Capital expenditures: 1515693.4306569342
Operating cash flow: 2934124.0875912406
Depreciation & amortization: 3372262.7737226277
Net tangible assets: 22027737.22627737
Owner earnings: 1949270.0729927006
Return on net tangible assets (%): 8.849161640930479
Capex to operating income (%): 26.183721076855175
Buffett classification: The Good
Stock price: 2.7700729927007295
P/E ratio: 199.7965680486173
Shares outstanding: 56987156
Book value: 65516970.802919686
P/B ratio: 2.4094304091267382
Market cap (USD): 157858581.76642334
Debt to equity: 2.033618079675128
Current ratio: 2.0622611753940685
Quick ratio: 2.047017296332932
Effective tax rate (%): 31.536388140161726
Interest coverage ratio: 1.2666506947771923
COGS to revenue (%): 80.15910736292948
SG&A to revenue (%): 2.8784671754712705
Free cash flow (dilution-adjusted): 894708.0291970802
Buyback yield (%): 0
Retained earnings: -52737.22627737226
Inventory turnover: 48.64034205231388
Receivables turnover: 0.9795400226821814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.055786748046424
FCF margin (%): 1.3548166037569012
Revenue growth (%): 3.1286676806163225
Rule of 40 score: 4.483484284373223
Financial ratios for PRNR3.SA — quarterly report dated 2025-09-30
Total revenue: 67506390.9774436
Gross profit: 13922744.360902255
Operating income: 4022180.4511278193
Net income: 575187.969924812
Capital expenditures: 2220488.7218045113
Operating cash flow: 9381390.97744361
Depreciation & amortization: 3501315.789473684
Net tangible assets: 51865037.59398496
Owner earnings: 1856015.0375939845
Return on net tangible assets (%): 3.5785475605424715
Capex to operating income (%): 55.2060940274792
Buffett classification: The Good
Stock price: 3.1785714285714284
P/E ratio: 132.6739895269713
Shares outstanding: 56987156
Book value: 96816353.38345864
P/B ratio: 1.870941628422154
Market cap (USD): 181137745.85714284
Debt to equity: 1.3470488076215918
Current ratio: 2.419245332966528
Quick ratio: 2.4039900443540123
Effective tax rate (%): 8.982748364069005
Interest coverage ratio: 0.7218567621360861
COGS to revenue (%): 79.37566479364249
SG&A to revenue (%): 3.281504953582785
Free cash flow (dilution-adjusted): 6987406.015037593
Buyback yield (%): 0
Retained earnings: -727255.6390977444
Inventory turnover: 48.496937733923104
Receivables turnover: 0.9486143248069141
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.82829664578739
FCF margin (%): 10.350732595632827
Revenue growth (%): 2.221927568954167
Rule of 40 score: 12.572660164586994
Financial ratios for PRNR3.SA — quarterly report dated 2025-12-31
Total revenue: 86450729.92700729
Gross profit: 16539416.05839416
Operating income: 4240693.430656934
Net income: 149452.55474452552
Capital expenditures: 1756386.8613138685
Operating cash flow: 13233211.678832116
Depreciation & amortization: 6097810.218978101
Net tangible assets: 22018978.10218978
Owner earnings: 4490875.912408759
Return on net tangible assets (%): 20.395478353112775
Capex to operating income (%): 41.417444812599506
Buffett classification: The Good
Stock price: 2.8563734290843805
P/E ratio: 107.4619480136763
Shares outstanding: 56987156
Book value: 102615693.43065694
P/B ratio: 1.586273919276135
Market cap (USD): 162776598.19748652
Debt to equity: 1.4962744561061574
Current ratio: 1.4757503158078145
Quick ratio: 1.4602291240144616
Interest coverage ratio: 0.6768706492296043
COGS to revenue (%): 80.86839050131928
SG&A to revenue (%): 3.3944063324538263
Free cash flow (dilution-adjusted): 10644343.06569343
Buyback yield (%): 0
Inventory turnover: 43.00785810507409
Receivables turnover: 1.1437738864652014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.7649185322901335
FCF margin (%): 12.312612137203168
Revenue growth (%): 28.063030292781743
Rule of 40 score: 40.37564242998491
Financial ratios for PRNR3.SA — annual report dated 2025-12-31
Total revenue: 285332664.2335766
Gross profit: 56632846.71532846
Operating income: 15888138.686131386
Net income: 1533576.6423357662
Capital expenditures: 5420985.401459853
Operating cash flow: 18244160.583941605
Depreciation & amortization: 16238503.649635036
Net tangible assets: 22018978.10218978
Owner earnings: 12351094.890510947
Return on net tangible assets (%): 56.09295233043824
Capex to operating income (%): 34.11970091998116
Buffett classification: The Good
Stock price: 2.8563734290843805
P/E ratio: 106.14180843910356
Shares outstanding: 56987156
Book value: 102615693.43065694
P/B ratio: 1.586273919276135
Market cap (USD): 162776598.19748652
Debt to equity: 1.4962744561061574
Current ratio: 1.4757503158078145
Quick ratio: 1.4602291240144616
Effective tax rate (%): -9.412836870199193
Interest coverage ratio: 0.8256474448332433
COGS to revenue (%): 80.15199315947643
SG&A to revenue (%): 3.1841434923891505
Free cash flow (dilution-adjusted): 9777189.781021897
Buyback yield (%): 0
Inventory turnover: 140.6909519533004
Receivables turnover: 3.7750525713485543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.612425743401397
FCF margin (%): 3.4265932389073326
Revenue growth (%): 60.220161947213725
Rule of 40 score: 63.646755186121055
Financial ratios for PUNJABCHEM.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 18.999472504285905
Shares outstanding: 12262185
Market cap (USD): 232975046.74996707
Buyback yield (%): 0
Retained earnings: 20043518.39641303
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PUNJABCHEM.NS — annual report dated 2023-03-31
Total revenue: 119205846.52862364
Gross profit: 40768574.90864799
Operating income: 12734470.158343485
Net income: 7442143.727161998
Capital expenditures: 4393422.6552984165
Operating cash flow: 7090133.982947625
Depreciation & amortization: 2315468.9403166873
Net tangible assets: 33968331.303288676
Owner earnings: 5364190.012180268
Return on net tangible assets (%): 15.791738382099826
Capex to operating income (%): 34.50023912003826
Buffett classification: The Good
Stock price: 9.97673568818514
P/E ratio: 16.438352064893618
Shares outstanding: 12262185
Book value: 34180267.96589524
P/B ratio: 3.579157975785761
Market cap (USD): 122336578.70462851
Debt to equity: 0.33486565462190876
Current ratio: 1.4791309319611208
Quick ratio: 0.7920444335538676
Effective tax rate (%): 31.255625562556254
Interest coverage ratio: 7.631386861313868
COGS to revenue (%): 65.79985286304002
SG&A to revenue (%): 2.5309600686639144
Free cash flow (dilution-adjusted): 2540803.8976857495
Buyback yield (%): 0
Retained earnings: 25389768.57490865
Inventory turnover: 3.827686638135996
Receivables turnover: 6.830541596873255
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 28.169962817265727
FCF margin (%): 2.13144235092165
Rule of 40 score: 2.13144235092165
Financial ratios for PUNJABCHEM.NS — annual report dated 2024-03-31
Total revenue: 109427988.9675021
Gross profit: 40049166.56673462
Operating income: 11057680.777071591
Net income: 6425230.843026741
Capital expenditures: 3758244.3938122075
Operating cash flow: 3584362.6334092817
Depreciation & amortization: 2657392.972778511
Net tangible assets: 39076627.89303274
Owner earnings: 5324379.421993045
Return on net tangible assets (%): 13.625483336402135
Capex to operating income (%): 33.98763691573582
Buffett classification: The Good
Stock price: 11.827135316698657
P/E ratio: 22.571410244472197
Shares outstanding: 12262185
Book value: 39592277.25146899
P/B ratio: 3.6630002450291386
Market cap (USD): 145026521.27339253
Debt to equity: 0.37203174218560703
Current ratio: 1.594727057630556
Quick ratio: 1.0342656751732298
Effective tax rate (%): 26.683087027914613
Interest coverage ratio: 5.949032258064516
COGS to revenue (%): 63.401350107394904
SG&A to revenue (%): 2.727611449612063
Free cash flow (dilution-adjusted): -401726.82575848425
Buyback yield (%): 0
Retained earnings: 30941359.875284806
Inventory turnover: 4.361477572559367
Receivables turnover: 4.621992604973915
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.87464959936494
FCF margin (%): -0.3671152413097795
Revenue growth (%): -8.20249832190377
Rule of 40 score: -8.569613563213549
Financial ratios for PUNJABCHEM.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 41532489.24988055
Buffett classification: The Gruesome
Stock price: 15.221452460582894
Shares outstanding: 12262185
Book value: 42007883.4209269
P/B ratio: 4.443172348630896
Market cap (USD): 186648266.04037264
Debt to equity: 0.35033694446813957
Current ratio: 1.5613706478624945
Quick ratio: 0.9736300866754811
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PUNJABCHEM.NS — quarterly report dated 2025-03-31
Total revenue: 23647416.413373858
Gross profit: 10284077.624503156
Operating income: 2218844.9848024314
Net income: 824175.8241758241
Capital expenditures: 0
Depreciation & amortization: 763385.5506195931
Net tangible assets: 41983867.19663315
Owner earnings: 1587561.3747954173
Return on net tangible assets (%): 3.7813605101216825
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.76543353950286
P/E ratio: 40.04234709219863
Shares outstanding: 12262185
Book value: 42636193.5936404
P/B ratio: 3.096142655808728
Market cap (USD): 132007737.66658887
Debt to equity: 0.46033835101861753
Current ratio: 1.5105427793546893
Quick ratio: 0.8664774372936338
Effective tax rate (%): 32.21153846153847
Interest coverage ratio: 3.995789473684211
COGS to revenue (%): 56.5107771405972
Buyback yield (%): 0
Retained earnings: 34244797.75543605
Inventory turnover: 0.5140531546521564
Receivables turnover: 0.8594128393593067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.168313787499451
Rule of 40 score: 0
Financial ratios for PUNJABCHEM.NS — annual report dated 2025-03-31
Total revenue: 103225391.62964694
Gross profit: 39631751.22749591
Operating income: 8835632.452653728
Net income: 4551087.210661679
Capital expenditures: 3855506.1959317275
Operating cash flow: 2948328.2674772036
Depreciation & amortization: 2927285.48047697
Net tangible assets: 41983867.19663315
Owner earnings: 3622866.495206921
Return on net tangible assets (%): 8.629187202405815
Capex to operating income (%): 43.63588250860016
Buffett classification: The Good
Stock price: 10.76543353950286
P/E ratio: 29.005758746468054
Shares outstanding: 12262185
Book value: 42636193.5936404
P/B ratio: 3.096142655808728
Market cap (USD): 132007737.66658887
Debt to equity: 0.46033835101861753
Current ratio: 1.5105427793546893
Quick ratio: 0.8664774372936338
Effective tax rate (%): 27.32872876610043
Interest coverage ratio: 4.438050499119201
COGS to revenue (%): 61.606586711061276
SG&A to revenue (%): 2.912830269878481
Free cash flow (dilution-adjusted): -980827.6829553425
Buyback yield (%): 0
Retained earnings: 34244797.75543605
Inventory turnover: 2.446283221657598
Receivables turnover: 3.751497642010452
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.598585672244916
FCF margin (%): -0.9501806362472961
Revenue growth (%): -5.668200061409523
Rule of 40 score: -6.61838069765682
Financial ratios for PUNJABCHEM.NS — quarterly report dated 2025-06-30
Total revenue: 37387081.67563773
Gross profit: 12361338.637959281
Operating income: 3260004.680552305
Net income: 2413994.8513924647
Capital expenditures: 0
Depreciation & amortization: 760589.7495904517
Owner earnings: 3174584.6009829165
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 14.838169904048678
P/E ratio: 18.843079172261266
Shares outstanding: 12262185
Market cap (USD): 181948384.42487714
Effective tax rate (%): 25.28069540021731
Interest coverage ratio: 7.035353535353535
COGS to revenue (%): 66.93687208538074
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 58.102183435537455
Rule of 40 score: 58.102183435537455
Financial ratios for PUNJABCHEM.NS — quarterly report dated 2025-09-30
Total revenue: 28766629.086809468
Gross profit: 11356257.046223223
Operating income: 2208568.2074408117
Net income: 2090191.6572717023
Capital expenditures: 0
Depreciation & amortization: 749718.1510710259
Net tangible assets: 44479143.17925592
Owner earnings: 2839909.8083427283
Return on net tangible assets (%): 6.384812308316225
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.243517474633595
P/E ratio: 35.07997760825382
Shares outstanding: 12262185
Book value: 45081172.49154454
P/B ratio: 4.146272623227548
Market cap (USD): 186918831.32468995
Debt to equity: 0.31020081526496107
Current ratio: 1.8112597647481368
Quick ratio: 1.1015084852294155
Effective tax rate (%): 15.303791685701235
Interest coverage ratio: 5.182539682539683
COGS to revenue (%): 60.52280921774573
Buyback yield (%): 0
Inventory turnover: 0.976848630526915
Receivables turnover: 1.4049887120753262
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.169327033584471
Revenue growth (%): -23.057302689783203
Rule of 40 score: -23.057302689783203
Financial ratios for PUNJABCHEM.NS — quarterly report dated 2025-12-31
Total revenue: 27466859.75270135
Gross profit: 11509412.94419071
Operating income: 2536482.1209758273
Net income: 1538375.849392893
Capital expenditures: 0
Depreciation & amortization: 757491.366826334
Owner earnings: 2295867.216219227
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 13.454049236938845
P/E ratio: 24.02538677960881
Shares outstanding: 12262185
Market cap (USD): 164976040.74245295
Effective tax rate (%): 25.792584631918324
Interest coverage ratio: 5.580882352941177
COGS to revenue (%): 58.09709210366224
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -4.518323402390268
Rule of 40 score: -4.518323402390268
Financial ratios for PVRINOX.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.3501252802321
Shares outstanding: 98199962
Market cap (USD): 2489381339.2140317
Buyback yield (%): 0
Retained earnings: -144127653.96281156
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PVRINOX.NS — annual report dated 2023-03-31
Total revenue: 455213154.6894032
Gross profit: 298708891.59561515
Operating income: 33568818.51400731
Net income: -40816077.95371498
Capital expenditures: 77222898.90377589
Operating cash flow: 105225334.95736907
Depreciation & amortization: 91753958.58708893
Net tangible assets: 175286236.29719856
Owner earnings: -26285018.27040194
Return on net tangible assets (%): -14.99548328816621
Capex to operating income (%): 230.0435413642961
Buffett classification: The Gruesome
Stock price: 18.684531059683316
Shares outstanding: 98199962
Book value: 892752740.5602922
P/B ratio: 2.0552389891261345
Market cap (USD): 1834820240.0487213
Debt to equity: 1.098560611228597
Current ratio: 0.4142738751035928
Quick ratio: 0.3819041583386145
Interest coverage ratio: 0.5088626292466765
COGS to revenue (%): 34.38043507344875
SG&A to revenue (%): 3.1867926042865173
Free cash flow (dilution-adjusted): 26029232.64311815
Buyback yield (%): 0
Retained earnings: -173800243.60535932
Inventory turnover: 19.350903614457835
Receivables turnover: 20.478356164383563
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9105189457484715
FCF margin (%): 5.71803173413962
Rule of 40 score: 5.71803173413962
Financial ratios for PVRINOX.NS — annual report dated 2024-03-31
Total revenue: 730159491.5457488
Gross profit: 478450653.5555822
Operating income: 72538673.70188272
Net income: -3837390.5744094015
Capital expenditures: 75176879.72178918
Operating cash flow: 237318623.33613142
Depreciation & amortization: 146216572.73054323
Net tangible assets: 173006355.67813885
Owner earnings: 67202302.43434465
Capex to operating income (%): 103.63696478756819
Buffett classification: The Gruesome
Stock price: 15.909908829174665
Shares outstanding: 98199962
Book value: 878186832.9535916
P/B ratio: 1.779066121036889
Market cap (USD): 1562352442.4484165
Debt to equity: 1.1338622460126722
Current ratio: 0.42288218525294646
Quick ratio: 0.392035059354125
Interest coverage ratio: 0.7894805533803184
COGS to revenue (%): 34.473130994613065
SG&A to revenue (%): 2.6195637892523984
Free cash flow (dilution-adjusted): 160582803.69348842
Buyback yield (%): 0
Retained earnings: -174901067.27425352
Inventory turnover: 28.951724137931034
Receivables turnover: 25.9539641943734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.180344296169342
FCF margin (%): 21.992839311522797
Revenue growth (%): 60.39947089049843
Rule of 40 score: 82.39231020202122
Financial ratios for PVRINOX.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 151015289.05876732
Buffett classification: The Gruesome
Stock price: 19.871595795508842
Shares outstanding: 98199962
Book value: 852854753.9417105
P/B ratio: 2.2880683293133153
Market cap (USD): 1951389951.998328
Debt to equity: 1.1666503270262323
Current ratio: 0.4451332420900088
Quick ratio: 0.41196361001529663
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PVRINOX.NS — quarterly report dated 2024-12-31
Total revenue: 200174845.55309474
Gross profit: 128045226.7164005
Operating income: 24198624.54831565
Net income: 4184636.904068073
Capital expenditures: 0
Depreciation & amortization: 37312041.03042313
Owner earnings: 41496677.9344912
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 15.210397482224035
P/E ratio: 89.23477048314764
Shares outstanding: 98199962
Market cap (USD): 1493660454.759296
Effective tax rate (%): 23.16017316017316
Interest coverage ratio: 1.0221565731166913
COGS to revenue (%): 36.033308099924305
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PVRINOX.NS — annual report dated 2025-03-31
Total revenue: 666343231.2368482
Gross profit: 439431844.75099367
Operating income: 32721533.78536357
Net income: -32686462.473696515
Capital expenditures: 37584755.66986205
Operating cash flow: 230009352.34977788
Depreciation & amortization: 149333645.07832593
Net tangible assets: 138274491.46598083
Owner earnings: 79062426.93476737
Capex to operating income (%): 114.86245087531259
Buffett classification: The Gruesome
Stock price: 10.649434006301785
Shares outstanding: 98199962
Book value: 824573299.0413842
P/B ratio: 1.2682608276985416
Market cap (USD): 1045774014.7403431
Debt to equity: 1.1022485609776844
Current ratio: 0.43279817432037476
Quick ratio: 0.4006886335428595
Interest coverage ratio: 0.3469691335068799
COGS to revenue (%): 34.053229004017616
SG&A to revenue (%): 2.856190459481745
Free cash flow (dilution-adjusted): 191337386.01823705
Buyback yield (%): 0
Retained earnings: -203214870.2361468
Inventory turnover: 24.20199501246883
Receivables turnover: 23.456378600823047
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.033462407462567
FCF margin (%): 28.714538851558796
Revenue growth (%): -8.740043928457531
Rule of 40 score: 19.974494923101265
Financial ratios for PVRINOX.NS — quarterly report dated 2025-03-31
Total revenue: 143780687.39770865
Gross profit: 96855272.38718727
Operating income: -3051204.115033902
Net income: -14613046.527940145
Capital expenditures: 0
Depreciation & amortization: 36883329.43652093
Net tangible assets: 138274491.46598083
Owner earnings: 22270282.90858078
Buffett classification: The Gruesome
Stock price: 10.649434006301785
Shares outstanding: 98199962
Book value: 824573299.0413842
P/B ratio: 1.2682608276985416
Market cap (USD): 1045774014.7403431
Debt to equity: 1.1022485609776844
Current ratio: 0.43279817432037476
Quick ratio: 0.4006886335428595
Interest coverage ratio: -0.13350383631713555
COGS to revenue (%): 32.63679973981625
Buyback yield (%): 0
Retained earnings: -203214870.2361468
Inventory turnover: 5.00498753117207
Receivables turnover: 5.061316872427983
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.18961546564763487
Revenue growth (%): -28.172449939734314
Rule of 40 score: -28.172449939734314
Financial ratios for PVRINOX.NS — quarterly report dated 2025-06-30
Total revenue: 169623215.53943366
Gross profit: 110929089.63257666
Operating income: 11233325.532412825
Net income: -6318745.611982214
Capital expenditures: 0
Depreciation & amortization: 36005148.60753569
Owner earnings: 29686402.995553475
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.35150947811842
Shares outstanding: 98199962
Market cap (USD): 1114717799.3938687
Interest coverage ratio: 0.502092050209205
COGS to revenue (%): 34.602649006622514
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 17.973573926686374
Rule of 40 score: 17.973573926686374
Financial ratios for PVRINOX.NS — quarterly report dated 2025-12-31
Total revenue: 209401804.61178568
Gross profit: 137529241.39467528
Operating income: 33986855.29686978
Net income: 10660577.030188259
Capital expenditures: 0
Depreciation & amortization: 35334744.3466637
Owner earnings: 45995321.37685196
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.30890052356021
P/E ratio: 26.04299932664577
Shares outstanding: 98199962
Market cap (USD): 1110533601.6753926
Effective tax rate (%): 20.03352891869237
Interest coverage ratio: 1.6865671641791045
COGS to revenue (%): 34.32280029790403
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 23.451146675794725
Rule of 40 score: 23.451146675794725
Financial ratios for RENUKA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.4694711855466175
Shares outstanding: 2128489773
Market cap (USD): 999264617.1541607
Buyback yield (%): 0
Retained earnings: -693828959.514704
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RENUKA.NS — annual report dated 2023-03-31
Total revenue: 1097080267.9658954
Gross profit: 186315712.54567602
Operating income: 58771132.76492083
Net income: -23954689.40316687
Capital expenditures: 48732155.90742996
Operating cash flow: 112840316.68696712
Depreciation & amortization: 28946772.22898904
Net tangible assets: -107365529.84165652
Owner earnings: -43740073.081607796
Capex to operating income (%): 82.91852413727355
Buffett classification: The Gruesome
Stock price: 0.5371498172959805
Shares outstanding: 2128489773
Book value: -107264799.02557862
Market cap (USD): 1143317892.6833131
Debt to equity: -6.323384931936172
Current ratio: 0.5877895897438956
Quick ratio: 0.14949458305289878
Interest coverage ratio: 0.8626542685663102
COGS to revenue (%): 83.0171302879118
SG&A to revenue (%): 3.5549236046647565
Free cash flow (dilution-adjusted): 64075152.25334958
Buyback yield (%): 0
Retained earnings: -655834226.5529842
Inventory turnover: 3.2815691929862134
Receivables turnover: 43.55977540696607
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 20.05945778754837
FCF margin (%): 5.840516334520516
Rule of 40 score: 5.840516334520516
Financial ratios for RENUKA.NS — annual report dated 2024-03-31
Total revenue: 1355053723.4680417
Gross profit: 223250749.49034655
Operating income: 57066314.905864015
Net income: -75206259.74337451
Capital expenditures: 19417915.817244273
Operating cash flow: 109528240.79625854
Depreciation & amortization: 31926130.23144262
Net tangible assets: -189567813.88655713
Owner earnings: -62698045.32917617
Capex to operating income (%): 34.02693138548697
Buffett classification: The Good
Stock price: 0.47624760076775435
Shares outstanding: 2128489773
Book value: -172361913.89854908
Market cap (USD): 1013688147.649952
Debt to equity: -4.031074370045485
Current ratio: 0.6791781111041703
Quick ratio: 0.11871323733296207
Interest coverage ratio: 0.5716022245444609
COGS to revenue (%): 83.52458314944354
SG&A to revenue (%): 2.0244087657180976
Free cash flow (dilution-adjusted): 88526442.0194268
Buyback yield (%): 1.2953757920765991
Retained earnings: -711434224.7271855
Inventory turnover: 2.1080731737606553
Receivables turnover: 18.28202892172883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 21.80220158821862
FCF margin (%): 6.533057729464602
Revenue growth (%): 23.51454702402557
Rule of 40 score: 30.047604753490173
Financial ratios for RENUKA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -206163401.81557572
Buffett classification: The Gruesome
Stock price: 0.6506211180124224
Shares outstanding: 2128489773
Book value: -189178213.0912565
Market cap (USD): 1384840395.7872672
Debt to equity: -3.5422401818411426
Current ratio: 0.5035579889782598
Quick ratio: 0.12095379072961064
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RENUKA.NS — quarterly report dated 2024-12-31
Total revenue: 288879822.82317287
Gross profit: 35120643.43163539
Operating income: -17426273.45844504
Net income: -23732369.74006294
Capital expenditures: 0
Depreciation & amortization: 8194428.2550413795
Owner earnings: -15537941.485021561
Buffett classification: The Gruesome
Stock price: 0.46007693204336164
Shares outstanding: 2128489773
Market cap (USD): 979269044.6475112
Interest coverage ratio: -0.7690329218106996
COGS to revenue (%): 87.84247266271234
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RENUKA.NS — annual report dated 2025-03-31
Total revenue: 1237912087.912088
Gross profit: 197895721.29997662
Operating income: 5681552.490063128
Net income: -35047930.79261164
Capital expenditures: 22001402.85246668
Operating cash flow: 111105915.3612345
Depreciation & amortization: 32686462.473696515
Net tangible assets: -212622866.4952069
Owner earnings: -24362871.17138181
Capex to operating income (%): 387.24279835390945
Buffett classification: The Gruesome
Stock price: 0.3218578597269226
Shares outstanding: 2128489773
Book value: -195837152.20949268
Market cap (USD): 685071162.7884233
Debt to equity: -3.5154540586715175
Current ratio: 0.5904533501784901
Quick ratio: 0.10041212625279262
Interest coverage ratio: 0.05992601726263872
COGS to revenue (%): 84.0137499881954
SG&A to revenue (%): 2.5403197627749288
Free cash flow (dilution-adjusted): 88742108.9548749
Buyback yield (%): 0
Retained earnings: -719490647.6502221
Inventory turnover: 2.564373816366356
Receivables turnover: 23.574658316506113
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.76414191309333
FCF margin (%): 7.168692334570453
Revenue growth (%): -8.64479640380225
Rule of 40 score: -1.4761040692317966
Financial ratios for RENUKA.NS — quarterly report dated 2025-03-31
Total revenue: 317161561.8424129
Gross profit: 94821136.310498
Operating income: 27273790.039747484
Net income: 10883797.05400982
Capital expenditures: 0
Depreciation & amortization: 8218377.367313537
Net tangible assets: -212622866.4952069
Owner earnings: 19102174.421323355
Return on net tangible assets (%): -8.984064007882225
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.3218578597269226
P/E ratio: 15.736033100140101
Shares outstanding: 2128489773
Book value: -195837152.20949268
Market cap (USD): 685071162.7884233
Debt to equity: -3.5154540586715175
Current ratio: 0.5904533501784901
Quick ratio: 0.10041212625279262
Effective tax rate (%): -2.4202420242024205
Interest coverage ratio: 1.2157373632100053
COGS to revenue (%): 70.10320678215997
Buyback yield (%): 0
Retained earnings: -719490647.6502221
Inventory turnover: 0.5482259547617744
Receivables turnover: 6.039989046536635
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.269018689808105
Revenue growth (%): 9.790139976841388
Rule of 40 score: 9.790139976841388
Financial ratios for RENUKA.NS — quarterly report dated 2025-06-30
Total revenue: 234905218.81582028
Gross profit: 20898666.04259303
Operating income: -17598876.66744676
Net income: -30774631.40650597
Capital expenditures: 0
Depreciation & amortization: 8460098.29159841
Owner earnings: -22314533.11490756
Buffett classification: The Gruesome
Stock price: 0.38754973086824246
Shares outstanding: 2128489773
Market cap (USD): 824895638.6819565
Interest coverage ratio: -0.7796785899429756
COGS to revenue (%): 91.10336239103363
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -25.935155114245234
Rule of 40 score: -25.935155114245234
Financial ratios for RENUKA.NS — quarterly report dated 2025-12-31
Total revenue: 236114514.87133786
Gross profit: 58092904.08822547
Operating income: 5436114.514871338
Net income: -4244179.570012254
Capital expenditures: 0
Depreciation & amortization: 8198730.088002674
Owner earnings: 3954550.5179904206
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.29107719728194276
Shares outstanding: 2128489773
Market cap (USD): 619554837.5681186
Effective tax rate (%): 261.4406779661017
Interest coverage ratio: 0.27338935574229695
COGS to revenue (%): 75.39630118890356
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 0.514801698154584
Rule of 40 score: 0.514801698154584
Financial ratios for RFG.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.0150375939849625
Shares outstanding: 63259405
Market cap (USD): 127470079.24812031
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RFG.AX — annual report dated 2022-06-30
Total revenue: 70741379.31034483
Gross profit: 51754482.758620694
Operating income: 1724827.5862068967
Net income: 3626896.551724138
Capital expenditures: 1968275.8620689656
Depreciation & amortization: 6045517.24137931
Net tangible assets: -28747586.20689655
Owner earnings: 7704137.931034483
Return on net tangible assets (%): -26.79925151137127
Capex to operating income (%): 114.11435425829669
Buffett classification: The Gruesome
Stock price: 1.0758620689655174
P/E ratio: 18.76491192241871
Shares outstanding: 63259405
Book value: 127506896.55172414
P/B ratio: 0.5337624566622495
Market cap (USD): 68058394.34482759
Debt to equity: 0.6945831192362821
Current ratio: 0.9632846705052581
Quick ratio: 0.8727070516520491
Effective tax rate (%): 4.275019700551615
Interest coverage ratio: 1.8498520710059172
COGS to revenue (%): 26.83987326346576
SG&A to revenue (%): 62.02193516938824
Free cash flow (dilution-adjusted): 8495862.068965517
Buyback yield (%): 0
Retained earnings: -302967586.20689654
Inventory turnover: 4.278986633509481
Receivables turnover: 3.796262028127313
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8927169148617199
FCF margin (%): 12.009748964172557
Rule of 40 score: 12.009748964172557
Financial ratios for RFG.AX — annual report dated 2023-06-30
Total revenue: 73757615.89403974
Gross profit: 53479470.1986755
Operating income: -9062251.65562914
Net income: -5924503.311258278
Capital expenditures: 1802649.0066225166
Depreciation & amortization: 5623178.80794702
Net tangible assets: -12377483.44370861
Owner earnings: -2103973.5099337744
Buffett classification: The Gruesome
Stock price: 1.509933774834437
Shares outstanding: 63259405
Book value: 134054304.63576157
P/B ratio: 0.7125284969025107
Market cap (USD): 95517512.18543047
Debt to equity: 0.5465611445396252
Current ratio: 1.2728839112642687
Quick ratio: 1.2001057310124723
Interest coverage ratio: -6.265567765567766
COGS to revenue (%): 27.492951676333792
SG&A to revenue (%): 69.00712913247258
Free cash flow (dilution-adjusted): -3599337.7483443706
Buyback yield (%): 0
Retained earnings: -294673509.9337748
Inventory turnover: 8.237826203927899
Receivables turnover: 3.6614504569662696
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.553349793362305
FCF margin (%): -4.879954028767934
Revenue growth (%): 4.26375144660747
Rule of 40 score: -0.6162025821604642
Financial ratios for RFG.AX — annual report dated 2024-06-30
Total revenue: 83452666.66666667
Gross profit: 60588000
Operating income: -1268000
Net income: 3860666.6666666665
Capital expenditures: 3133333.3333333335
Depreciation & amortization: 5546666.666666667
Net tangible assets: -14142666.666666666
Owner earnings: 6274000
Return on net tangible assets (%): -44.36221363250684
Buffett classification: The Gruesome
Stock price: 2.1333333333333333
P/E ratio: 34.95598273182525
Shares outstanding: 63259405
Book value: 140621333.33333334
P/B ratio: 0.9596936263819619
Market cap (USD): 134953397.33333334
Debt to equity: 0.5386522670813342
Current ratio: 1.219798374227946
Quick ratio: 1.1468263652918316
Effective tax rate (%): 33.80957823751285
Interest coverage ratio: -0.5921544209215441
COGS to revenue (%): 27.39836554054594
SG&A to revenue (%): 64.76645443724587
Free cash flow (dilution-adjusted): 8517333.333333334
Buyback yield (%): 0
Retained earnings: -291884000
Inventory turnover: 8.823514278363776
Receivables turnover: 3.742607707716686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.597374942288304
FCF margin (%): 10.206184743447382
Revenue growth (%): 13.144474174104076
Rule of 40 score: 23.350658917551456
Financial ratios for RFM — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.29
Shares outstanding: 6114699
Market cap (USD): 93493747.71
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RFM — annual report dated 2022-06-30
Total revenue: -26058636
Net income: -26127423
Capital expenditures: 0
Operating cash flow: -7237783
Net tangible assets: 110982112
Owner earnings: -26127423
Return on net tangible assets (%): -23.54201278851136
Buffett classification: The Gruesome
Stock price: 12.02
Shares outstanding: 6114699
Book value: 110982112
P/B ratio: 0.6622570129139369
Market cap (USD): 73498681.98
Debt to equity: 0.7942721436045477
Free cash flow (dilution-adjusted): -7237783
Buyback yield (%): 0
Retained earnings: -11425813
Receivables turnover: -20.05598112822723
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RFM — annual report dated 2023-06-30
Total revenue: 3549395
Net income: 3299792
Capital expenditures: 0
Operating cash flow: 28558781
Net tangible assets: 104101420
Owner earnings: 3299792
Return on net tangible assets (%): 3.1697857723746705
Buffett classification: The Gruesome
Stock price: 12.7
P/E ratio: 23.53380979770846
Shares outstanding: 6114699
Book value: 104101420
P/B ratio: 0.745971354665479
Market cap (USD): 77656677.3
Debt to equity: 0.6788572144356917
COGS to revenue (%): 0
SG&A to revenue (%): 1.9948751829537148
Free cash flow (dilution-adjusted): 28558781
Buyback yield (%): 0
Retained earnings: -13129754
Receivables turnover: 1.9306800361397876
Capitalized R&D asset: 0
FCF margin (%): 804.609827872074
Rule of 40 score: 804.609827872074
Financial ratios for RFM — annual report dated 2024-06-30
Total revenue: 7925481
Net income: 7764369
Capital expenditures: 0
Operating cash flow: 13141212
Net tangible assets: 104751948
Owner earnings: 7764369
Return on net tangible assets (%): 7.412147600348205
Buffett classification: The Gruesome
Stock price: 13.93
P/E ratio: 10.970338616054956
Shares outstanding: 6114699
Book value: 104751948
P/B ratio: 0.81313769047999
Market cap (USD): 85177757.07
Debt to equity: 0.6161221937371513
COGS to revenue (%): 0
SG&A to revenue (%): 2.0328356095989633
Free cash flow (dilution-adjusted): 13141212
Buyback yield (%): 0
Retained earnings: -6861157
Receivables turnover: 4.6198116979939865
Capitalized R&D asset: 0
FCF margin (%): 165.8096461274716
Revenue growth (%): 123.29103974057551
Rule of 40 score: 289.1006858680471
Financial ratios for RFM — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 102609878
Buffett classification: The Gruesome
Stock price: 13.26
Shares outstanding: 6114699
Book value: 102609878
P/B ratio: 0.7901861918206354
Market cap (USD): 81080908.74
Debt to equity: 0.6578801311897087
Buyback yield (%): 0
Retained earnings: -9003227
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RFM — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 93840300
Buffett classification: The Gruesome
Stock price: 12.93
Shares outstanding: 6114699
Book value: 93840300
P/B ratio: 0.8425277633383526
Market cap (USD): 79063058.07
Debt to equity: 0.6572336192446102
Buyback yield (%): 0
Retained earnings: -13323787
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for RFM — annual report dated 2025-06-30
Total revenue: -3693241
Net income: -3962904
Capital expenditures: 0
Operating cash flow: 10030558
Net tangible assets: 93840300
Owner earnings: -3962904
Return on net tangible assets (%): -4.2230299775256475
Buffett classification: The Gruesome
Stock price: 12.93
Shares outstanding: 6114699
Book value: 93840300
P/B ratio: 0.8425277633383526
Market cap (USD): 79063058.07
Debt to equity: 0.6572336192446102
Free cash flow (dilution-adjusted): 10030558
Buyback yield (%): 0
Retained earnings: -13323787
Receivables turnover: -1.9437803613627154
Capitalized R&D asset: 0
Revenue growth (%): -146.5995817793267
Rule of 40 score: -146.5995817793267
Financial ratios for SANDHAR.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8020572332849794
Shares outstanding: 60190708
Market cap (USD): 168657808.72794408
Buyback yield (%): 0
Retained earnings: 62721350.38902809
Capitalized R&D asset: 88790.71607543189
Rule of 40 score: 0
Financial ratios for SANDHAR.NS — annual report dated 2023-03-31
Total revenue: 349102521.31546897
Gross profit: 107113970.76735689
Operating income: 15688440.925700366
Net income: 8959390.986601707
Capital expenditures: 30469610.23142509
Operating cash flow: 37503154.68940317
Depreciation & amortization: 14801887.941534715
Net tangible assets: 104036090.13398296
Owner earnings: -6708331.303288668
Return on net tangible assets (%): -6.448080944458158
Capex to operating income (%): 194.2169421150742
Buffett classification: The Gruesome
Stock price: 2.4113276492082827
P/E ratio: 16.199708065299376
Shares outstanding: 60190708
Book value: 112657137.63702804
P/B ratio: 1.2883295410313875
Market cap (USD): 145139518.42582217
Debt to equity: 0.7098282858610482
Current ratio: 0.9967147574778833
Quick ratio: 0.6132507589624964
Effective tax rate (%): 26.710174963134186
Interest coverage ratio: 3.783045301816302
COGS to revenue (%): 69.3173310912405
R&D to revenue (%): 0.03183384769094875
SG&A to revenue (%): 1.729459954683869
Free cash flow (dilution-adjusted): 6242643.1181486
Buyback yield (%): 0
Retained earnings: 65166577.34470159
Inventory turnover: 6.612600288571471
Receivables turnover: 8.411195532234588
Capitalized R&D asset: 170622.54469136763
ROCI (R&D-adjusted, %): 9.405799807452087
FCF margin (%): 1.7881976602819754
Rule of 40 score: 1.7881976602819754
Financial ratios for SANDHAR.NS — annual report dated 2024-03-31
Total revenue: 416312963.18503416
Gross profit: 134698405.0845425
Operating income: 22699364.43218611
Net income: 13222328.816404844
Capital expenditures: 27952632.210097134
Operating cash flow: 32955510.253027942
Depreciation & amortization: 18421957.06919295
Net tangible assets: 113700023.9836911
Owner earnings: 3691653.675500661
Return on net tangible assets (%): 3.2468363208350635
Capex to operating income (%): 123.14279676686566
Buffett classification: The Gruesome
Stock price: 6.217490403071017
P/E ratio: 28.30327051613927
Shares outstanding: 60190708
Book value: 121908130.47127956
P/B ratio: 3.069812882022797
Market cap (USD): 374235149.3440499
Debt to equity: 0.7220255246967833
Current ratio: 0.9491222930560053
Quick ratio: 0.6011075178868673
Effective tax rate (%): 26.59357603081631
Interest coverage ratio: 3.852455179515985
COGS to revenue (%): 67.64491692643388
R&D to revenue (%): 0.03340502100192711
SG&A to revenue (%): 1.781285226569692
Free cash flow (dilution-adjusted): 4507878.642523084
Buyback yield (%): 0
Retained earnings: 75515481.47259863
Inventory turnover: 6.970607721031291
Receivables turnover: 7.7465940510503515
Capitalized R&D asset: 242829.3215875532
ROCI (R&D-adjusted, %): 12.969113209518662
Rosenberg metric: 248.2115363262757
FCF margin (%): 1.082810059056344
Revenue growth (%): 19.25235074679681
Rule of 40 score: 20.335160805853157